about
ThrombopoietinProtein tyrosine phosphatase, non-receptor type 11T cell acute lymphocytic leukemia 1Protein tyrosine phosphatase non-receptor type 6Abl interactor 1Zinc finger protein, FOG family member 1SH2B adaptor protein 3Meis homeobox 1Fli-1 proto-oncogene, ETS transcription factorWASP family member 2Phosphatidylinositol-5-phosphate 4-kinase type 2 alphaVPS33B late endosome and lysosome associatedZinc finger protein 385AMegakaryocyte and platelet inhibitory receptor G6bSerum response factor (C-fos serum response element-binding transcription factor), isoform CRA_aMediator complex subunit 1TescalcinMeis homeobox 1WAS protein family, member 2Zinc finger protein, multitype 1Abl-interactor 1E1A binding protein p300Protein tyrosine phosphatase, non-receptor type 6Friend leukemia integration 1RAB GTPase activating protein 1-likeMediator complex subunit 1Neurobeachin-like 2KIT proto-oncogene receptor tyrosine kinasePhosphatidylinositol-5-phosphate 4-kinase, type II, alphaSerum response factorVacuolar protein sorting 33BSH2B adaptor protein 3Zinc finger protein 385AProtein tyrosine phosphatase, non-receptor type 11VPS33B, late endosome and lysosome associatedMegakaryocyte and platelet inhibitory receptor G6bMediator complex subunit 1TAL bHLH transcription factor 1, erythroid differentiation factorMeis homeobox 1Fli-1 proto-oncogene, ETS transcription factor
P682
Q14862703-6F206590-3471-404F-A8EB-BC03141C66FBQ14862703-E0FC1E5B-FA60-4373-8E24-BA3BDC00BBF4Q14905498-B4029477-E25A-4092-BFCD-6B4F3AD36857Q14914630-EC6D5F24-9320-4A08-A64C-399F8AFB5C0FQ21100543-D425F98B-1E69-4233-90D8-4BC709D8C562Q21104840-5A6811D7-C83B-401C-A27C-79EA9AF05D3CQ21107363-3DA3D5A0-004A-4426-912A-0C4244940E33Q21110148-F151C9A0-7858-470F-84F3-C64B9C69FF12Q21110790-EEF7C144-CD86-44CA-B57F-AC8C3021FC41Q21114539-7B3EADB9-5B10-4691-A113-C670E771C257Q21115482-A48D92D1-F5DA-4EA2-BF04-EC426DB5B203Q21119718-BAD79190-124F-44DE-AB78-03B870713169Q21135669-ED985601-AD96-4EBD-9E5D-A0C00F4EA12DQ21136618-C0E064B1-195B-4AAA-BA8B-D1FE29105622Q21142368-3F087B46-315C-4EBF-BAC4-6E1AE437C211Q21142368-E5D91031-44E0-4970-93F3-C18223AE26BEQ21143733-859FD842-779E-44AD-9D0E-C1231A10102FQ21173409-60447EEA-C567-4335-9CFB-B547A200A700Q21494226-98563135-342A-46CA-85C4-E992346E92DDQ21495981-7ACCFE57-E641-44A3-A3C5-5227A557219DQ21497828-D938781B-960C-4448-9E6C-1B4319F6215CQ21498462-F41B2390-3CB9-4DC9-B8EB-72EC2C7EB59FQ21498768-0E9C3BDD-4366-44D3-9313-DE9F22A2DCE5Q21498768-2A13BC83-5768-43B7-B038-3A6A6ACCDF9AQ21981065-944E67E7-5BE4-4613-9911-E597753372F8Q21983012-A8B00D34-CE8E-4DF0-B519-78E00DC773A1Q21985031-F240A121-2858-4F1A-8994-3099F288305BQ21985297-CA25BA68-D328-427D-976C-985AB3E79502Q21985771-DFBDE66A-C0EF-4BFD-81C6-B7BF707B4EADQ21985842-A39C2D64-9589-47BD-B5C1-ED981BE9F082Q21987135-B1F5310D-0289-4888-BFFE-944377B58B9EQ21988424-A2DB630D-A11E-48C3-9BD5-731AA4FB1CDEQ21990643-0E6E258F-53E6-4AE2-805B-0B9BED3DF0EBQ21990939-743F371C-0EAF-474F-80A3-51996458B9A0Q21991444-C738CA6F-2E12-415A-A411-2273A8E3F2B5Q21992423-2DB513FF-5A05-4CDA-91EE-E00C78D6F046Q28557971-5E0DC5F2-D917-4EE4-84C3-5B1A30460602Q28558990-96E409A2-1270-4ABA-A65F-6A6055D2BBBCQ28560143-013601A5-48BE-4F98-BFAF-0B9C3056A109Q29517584-7810A90A-B5E3-4B82-B0A0-08A0E6E09D6C
P682
description
The process whose specific out ...... megakaryocyte fate. A megakar
@en
biologisch proces
@nl
name
megakaryocyte development
@en
type
label
megakaryocyte development
@en
altLabel
GO:0035855
@en
megakaryocyte cell development
@en
prefLabel
megakaryocyte development
@en
P2888
P686
GO:0035855